Literature DB >> 40803

Do neuroleptics prevent the penetration of dopamine agonists into the brain?

B H Westerink, A S Horn.   

Abstract

A new, specific and highly sensitive method for the determination of apomorphine based on high performance liquid chromatography on a C18 reverse-phase column, coupled with electrochemical detection has been developed. The limit of detection of the assay is approximately 0.5 ng/sample (2 pmol). Haloperidol, cis-flupenthixol, metoclopramide and reserpine prevented the accumulation of apomorphine equally in "dopaminergic" as well as in "non-dopaminergic" brain areas. The non-neuroleptic trans-isomer of flupenthixol was without effect. Suppression of the accumulation of the dopamine agonist 6,7-ADTN (administered as the prodrug dibenzoyl-6,7-ADTN) was seen after combined treatment with haloperidol or reserpine, whereas cis- and trans-flupenthixol were without effect. The results imply that certain behavioural, biochemical and neuropharmacological studies, based on apomorphine in combination with other drugs, may need reinterpretation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 40803     DOI: 10.1016/0014-2999(79)90337-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Autoradiographic localisation of 3H-apomorphine binding sites in rat brain.

Authors:  M L Bouthenet; N Sales; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

2.  Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine.

Authors:  A Campbell; R J Baldessarini; M H Teicher; J L Neumeyer
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations.

Authors:  P A LeDuc; G Mittleman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine.

Authors:  G Laschinski; B Kittner; M Bräutigam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

5.  Inhibition of rat brain monoamine oxidase type A by 2-aminotetralin and tetrahydroisoquinoline analogues of dopamine.

Authors:  M G Feenstra; T van der Velden; D Dijkstra; O R Hommes; A S Horn
Journal:  Pharm Weekbl Sci       Date:  1983-08-26

6.  Regulation of aromatic L-amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists.

Authors:  M Y Zhu; A V Juorio; I A Paterson; A A Boulton
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

7.  Brain and serum concentrations of dopamine analogues after peripheral administration to rats.

Authors:  M G Feenstra; J W Homan; R Everts; H Rollema; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

8.  Prolonged antidopaminergic actions of single doses of butyrophenones in the rat.

Authors:  A Campbell; R J Baldessarini; M H Teicher; N S Kula
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.